Intellia Therapeutics (DE:38I)
FRANKFURT:38I
Want to see DE:38I full AI Analyst Report?
38I Analyst Ratings
Moderate Buy
9 Buy
7 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
38I Stock 12 Month Forecast
Average Price Target
€19.33
▲(65.24% Upside)
| Highest Price Target€49.47 | Average Price Target€19.33 | Lowest Price Target€7.68 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
€40.94→€49.47
Buy
322.82%
Upside
Reiterated
04/28/26
Citizens JMP
€23.88→€25.59
Buy
118.70%
Upside
Reiterated
04/28/26
Goldman Sachs
€6.82→€7.68
Sell
-34.39%
Downside
Reiterated
04/28/26
Evercore ISI
€13.65
Hold
16.64%
Upside
Reiterated
04/28/26
JonesTrading
€24.73
Buy
111.41%
Upside
Reiterated
04/27/26
William Blair
€11.09
Buy
-5.23%
Downside
Reiterated
04/27/26
Chardan Capital
€25.59
Buy
118.70%
Upside
Reiterated
04/27/26
Morgan Stanley
€9.38→€12.79
Hold
9.35%
Upside
Assigned
04/27/26
Bank of America Securities
€16.21→€17.06
Hold
45.80%
Upside
Reiterated
04/27/26
Leerink Partners
€29.85
Buy
155.15%
Upside
Reiterated
04/27/26
Robert W. Baird
€5.97→€11.09
Hold
-5.23%
Downside
Reiterated
04/27/26
Wells Fargo
€10.24→€12.79
Hold
9.35%
Upside
Reiterated
03/03/26
H.C. Wainwright
€21.32→€25.59
Buy
118.70%
Upside
Reiterated
03/03/26
Truist Financial
―
Buy
―
Reiterated
03/02/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
€40.94→€49.47
Buy
322.82%
Upside
Reiterated
04/28/26
Citizens JMP
€23.88→€25.59
Buy
118.70%
Upside
Reiterated
04/28/26
Goldman Sachs
€6.82→€7.68
Sell
-34.39%
Downside
Reiterated
04/28/26
Evercore ISI
€13.65
Hold
16.64%
Upside
Reiterated
04/28/26
JonesTrading
€24.73
Buy
111.41%
Upside
Reiterated
04/27/26
William Blair
€11.09
Buy
-5.23%
Downside
Reiterated
04/27/26
Chardan Capital
€25.59
Buy
118.70%
Upside
Reiterated
04/27/26
Morgan Stanley
€9.38→€12.79
Hold
9.35%
Upside
Assigned
04/27/26
Bank of America Securities
€16.21→€17.06
Hold
45.80%
Upside
Reiterated
04/27/26
Leerink Partners
€29.85
Buy
155.15%
Upside
Reiterated
04/27/26
Robert W. Baird
€5.97→€11.09
Hold
-5.23%
Downside
Reiterated
04/27/26
Wells Fargo
€10.24→€12.79
Hold
9.35%
Upside
Reiterated
03/03/26
H.C. Wainwright
€21.32→€25.59
Buy
118.70%
Upside
Reiterated
03/03/26
Truist Financial
―
Buy
―
Reiterated
03/02/26
Best Analysts Covering Intellia Therapeutics
3 Months
xxx
Success Rate
15/36 ratings generated profit
Average Return
+13.61%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of +13.61% per trade.
1 Year
2 Years
xxx
Success Rate
8/26 ratings generated profit
Average Return
-26.10%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of -26.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
38I Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
7
2
6
10
10
Buy
5
3
5
4
3
Hold
22
13
22
15
13
Sell
1
0
1
2
2
Strong Sell
0
0
0
0
0
total
35
18
34
31
28
Each month's total comprises the sum of three months' worth of ratings.
38I Financial Forecast
38I Stock Forecast FAQ
What is DE:38I’s average 12-month price target, according to analysts?
Based on analyst ratings, Intellia Therapeutics’s 12-month average price target is 19.33.
What is DE:38I’s upside potential, based on the analysts’ average price target?
Intellia Therapeutics has 65.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Intellia Therapeutics a Buy, Sell or Hold?
Intellia Therapeutics has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 7 hold ratings and 2 sell ratings.
What is Intellia Therapeutics’s share price target?
The average share price target for Intellia Therapeutics is 19.33. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €49.47 ,and the lowest forecast is €7.68. The average share price target represents 65.24% Increase from the current price of €11.7.
The highest analyst share price target is €49.47 ,and the lowest forecast is €7.68. The average share price target represents 65.24% Increase from the current price of €11.7.
What do analysts say about Intellia Therapeutics?
Intellia Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of Intellia Therapeutics?
To buy shares of DE:38I, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.